What is the fair value of Adapthealth Corp (NASDAQ-AHCO) stock?

The current fair value estimate for Adapthealth Corp (NASDAQ-AHCO) is $6.88. This implies an estimated upside of 19.2% versus the current market price.

Is Adapthealth Corp (NASDAQ-AHCO) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 19.2% versus the current market price.

What is the analyst price target for NASDAQ-AHCO stock?

The available analyst price target for Adapthealth Corp (NASDAQ-AHCO) is $9. The analyst target implies estimated upside of 56.0%.

How is the financial health of Adapthealth Corp?

The current financial health read for Adapthealth Corp (NASDAQ-AHCO) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Adapthealth Corp's next earnings date?

The next earnings date currently listed for Adapthealth Corp (NASDAQ-AHCO) is November 10, 2026.

Does Adapthealth Corp (NASDAQ-AHCO) pay dividends?

The latest available data indicates no current dividend yield for Adapthealth Corp (NASDAQ-AHCO).

What is the market capitalization of Adapthealth Corp?

The current market capitalization listed for Adapthealth Corp is 769.8 M.

What is the enterprise value of Adapthealth Corp?

The current enterprise value listed for Adapthealth Corp is 2.797 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Adapthealth Corp?

The ticker symbol for Adapthealth Corp is NASDAQ-AHCO, and the stock is listed on NASDAQ.

Where is Adapthealth Corp (NASDAQ-AHCO) listed?

Adapthealth Corp (NASDAQ-AHCO) is listed on NASDAQ.

What is the debt-to-total-capital ratio for Adapthealth Corp?

The current debt-to-total-capital ratio listed for Adapthealth Corp is 72.6%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Adapthealth Corp?

The free float listed for Adapthealth Corp is 64.3%. Free float helps investors understand how much of the share base is available for public trading.

Adapthealth Corp (AHCO) Fair Value & Stock Analysis

Adapthealth Corp (AHCO)

AdaptHealth Corp. is a U.S.-based healthcare company that distributes home medical equipment, medical supplies, and related home care services. Through its Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments, the company serves patients and care providers with products and support used in the treatment of sleep apnea, respiratory conditions, diabetes, and post-acute care needs. Its offerings include CPAP and BiLevel therapy equipment, oxygen and ventilation systems, continuous glucose monitors, insulin pumps, wheelchairs, hospital beds, and a range of other home medical products such as wound care, orthopedic, breast pump, mobility, enteral, and incontinence supplies. AdaptHealth also works with Medicare, Medicaid, and commercial insurance beneficiaries. Founded in 2012, the company is headquartered in Conshohocken, Pennsylvania.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Yield	Next Earnings Date	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
NASDAQ-AHCO	$6.88	19.2% Upside	Undervalued	$9	56.0% Upside	Bargain	Fair	0.0%	November 10, 2026	0.6x	0.2x	769.8 M	2.797 B	72.6%	64.3%	1.6	-42.3%